-
Start Preamble
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on October 20, 2003, Siegfried (USA), Inc., Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal and on January 21, 2004, by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:
Drug Schedule Oxycodone (9143) II Morphine (9300) II The firm plans to manufacture the listed controlled substances for distribution as bulk products to its customers.
Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: Federal Register Representative, Office of Chief Counsel (CCD) and must be filed no later than April 19, 2004.
Start SignatureStart Printed Page 7658End Signature End PreambleDated: February 4, 2004.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 04-3477 Filed 2-17-04; 8:45 am]
BILLING CODE 4410-09-M
Document Information
- Published:
- 02/18/2004
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- 04-3477
- Pages:
- 7657-7658 (2 pages)
- PDF File:
- 04-3477.pdf